Eagle Asset Management Inc. trimmed its position in Bruker Co. (NASDAQ:BRKR) by 0.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 487,002 shares of the medical research company’s stock after selling 3,935 shares during the period. Eagle Asset Management Inc. owned 0.31% of Bruker worth $16,290,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently made changes to their positions in BRKR. SG Americas Securities LLC bought a new position in shares of Bruker in the 2nd quarter valued at $101,000. Sun Life Financial INC acquired a new stake in Bruker during the 2nd quarter worth about $163,000. Private Advisor Group LLC acquired a new stake in Bruker during the 3rd quarter worth about $210,000. First Hawaiian Bank acquired a new stake in Bruker during the 3rd quarter worth about $248,000. Finally, Meeder Asset Management Inc. grew its holdings in Bruker by 387.2% during the 3rd quarter. Meeder Asset Management Inc. now owns 8,146 shares of the medical research company’s stock worth $271,000 after acquiring an additional 6,474 shares during the period. Institutional investors own 64.87% of the company’s stock.
A number of analysts have weighed in on BRKR shares. BidaskClub downgraded Bruker from a “buy” rating to a “hold” rating in a report on Wednesday, September 19th. ValuEngine downgraded Bruker from a “buy” rating to a “hold” rating in a research note on Thursday, November 15th. Zacks Investment Research raised shares of Bruker from a “hold” rating to a “strong-buy” rating and set a $38.00 target price on the stock in a research report on Monday, November 12th. Morgan Stanley cut shares of Bruker from an “equal weight” rating to an “underweight” rating and lifted their target price for the stock from $31.00 to $32.00 in a research report on Thursday, September 20th. Finally, UBS Group initiated coverage on shares of Bruker in a research report on Tuesday, October 9th. They set a “sell” rating and a $30.00 target price on the stock. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, five have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Bruker presently has a consensus rating of “Hold” and an average target price of $35.13.
Bruker stock opened at $32.01 on Friday. Bruker Co. has a 1-year low of $28.13 and a 1-year high of $36.49. The company has a market capitalization of $5.16 billion, a P/E ratio of 26.46, a price-to-earnings-growth ratio of 2.01 and a beta of 1.39. The company has a quick ratio of 1.32, a current ratio of 2.24 and a debt-to-equity ratio of 0.27.
Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Thursday, November 1st. The medical research company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.07. The business had revenue of $466.60 million during the quarter, compared to the consensus estimate of $451.88 million. Bruker had a net margin of 5.24% and a return on equity of 27.46%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.29 earnings per share. Sell-side analysts forecast that Bruker Co. will post 1.4 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Stockholders of record on Monday, December 3rd will be paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend is Friday, November 30th. Bruker’s dividend payout ratio (DPR) is 13.22%.
COPYRIGHT VIOLATION WARNING: “Eagle Asset Management Inc. Has $16.29 Million Position in Bruker Co. (BRKR)” was originally posted by Fairfield Current and is the property of of Fairfield Current. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.fairfieldcurrent.com/news/2018/12/07/eagle-asset-management-inc-sells-3935-shares-of-bruker-co-brkr.html.
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Featured Article: Using the New Google Finance Tool
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.